---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-019301"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2022-07-14T23:59:59+00:00"
generated_at: "2026-06-24T15:05:28.698376+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Processa shareholders approve 3M share increase to Omnibus Incentive Plan; director Islam retires

## Summary
- Shareholders approved amendment to 2019 Omnibus Incentive Plan, raising share authorization from 3M to 6M shares.
- Dr. Khalid Islam retired from the Board effective as of the July 11, 2022 Annual Meeting.
- All five director nominees were elected; say-on-pay and auditor ratification passed.
- BD & Company, Inc. ratified as independent auditor for 2022.

## SEC filing metadata
- accession: 0001493152-22-019301
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2022-07-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315222019301/0001493152-22-019301-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315222019301/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-019301
- JSON: https://secwatch.observer/filing/0001493152-22-019301.json
- Plain text: https://secwatch.observer/filing/0001493152-22-019301.txt

## Key facts
- Executive change
  Khalid Islam retired as member of the Board of Directors at Processa Pharmaceuticals, Inc..
  - Action: retired
  - Role: member of the Board of Directors
  source text: Dr. Khalid Islam, who served as a member of the Board of Directors of the Company (the “Board”) since November 2020, retired from the Board Company effective as of the Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533743/000149315222019301/0001493152-22-019301-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.